Daisy Yuill
AstraZeneca (Brazil)(BR)
Publications by Year
Research Areas
Virus-based gene therapy research, Biosimilars and Bioanalytical Methods, CAR-T cell therapy research, PI3K/AKT/mTOR signaling in cancer, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase 1b and Extension Studies(2020)32 cited
- → Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements(2024)23 cited
- → A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform(2023)9 cited
- → Effectively Utilizing the Sponsor Contract Research Organization Interaction for Successful Implementation of Critical Flow Cytometry in the Clinic(2021)2 cited
- → Challenges in Development and Qualification of PCR/dPCR Assays for Gene Therapy Biodistribution and Viral Shedding Assessment(2023)1 cited
- → 2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS ( PART 3A – Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity & Technologies; Biotherapeutics & Biosimilars Immunogenicity Assessment & Clinical Relevance PART 3B – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)(2025)